- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06096402
Gastropexy as a Treatment Option for Paraesophageal Hernia
Selective Anterior Gastropexy as a Surgical Treatment Option for Paraesophageal Hernia
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
A hiatal hernia is a widening of the diaphragmatic hiatus causing herniation of the stomach into the thoracic cavity. It develops because of an insufficiency of the hiatus. The paraesophageal hernias (PEH) are classified as grade II-IV hiatal hernia with at least 50 % of the stomach misplaced in the thoracic cavity.
A paraesophageal hernia (PEH) is a potentially dangerous condition. One see in varied degree, the stomach and other organs being misplaced above diaphragm, in the thoracic cavity. Symptoms such as dysphagia, vomitus, weight loss, pain, short breath and emergent situations where abdominal organs are strangulated with risk of tissue death in thorax defines whether a patient should be offered operation and how fast it should be performed.
The operative management of PEH has become a laparoscopic procedure within the last 20-30 years with a concomitant significant decrease in morbidity and length of hospital stay. It is managed by different subspecialized surgeons, all of them having different perspectives and approaches to this condition. Surgery in this area is potentially high-risk operations with risk of perforation of oesophagus, injury to lungs, aorta, pericardia, spleen and stomach. Without operation symptomatic patients with PEH are at risk of developing an acute surgical condition with organ perforation with high per-and postoperative mortality.
Contemporary surgical technique is divided into three crucial steps; 1) removal of the hernia sac, 2) hiatoplasty with or without mesh and 3) an anti-reflux procedure and/or gastropexy. Each step is managed differently among surgeons/centres worldwide with varying evidence. Many surgeons add an anti-reflux procedure to the surgical management of PEH, to protect against postoperative acid reflux. The argument is that an anti-reflux procedure lowers postoperative reflux and recurrence of the paraesophageal hernia, but this is without clear evidence. As an addition or an alternative in step three of the PEH procedure, some centres do an anterior gastropexy to anchor the stomach in the abdominal cavity. It is a simple technique compared with an anti-reflux procedure with possibly equal satisfactory long-term outcomes but less postoperative complications. However, evidence is sparse and larger studies on this technique are highly warranted.
The aim is to study the need of a fundoplication as part of the procedure for PEH regarding symptom control and quality of life. For this reason, The investigator want to set up a prospective two-armed multicenter study in collaboration with St. Olav's Hospital, Trondheim and Gastroenheden, Hvidovre, Denmark. The reason for this collaboration is 1) to enlarge the group of investigation, as PEH is a rare condition, 2) to compare current practice (fundoplication/no fundoplication) among the included institutions. .
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Lene Osterballe, MD
- Phone Number: +4797572401
- Email: lene.osterballe@unn.no
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Both emergent and elective repair of the paraoesophageal hernia
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
anterior gastropexy, no fundoplication
patients with indication of operative management of a paraesophageal hernia
|
no intervention
|
|
anterior gastropexy and fundoplication
patients with indication of operative management of a paraesophageal hernia
|
no intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
peri- and postoperative complications
Time Frame: 30 days after operation
|
according to clavien-dindo score
|
30 days after operation
|
|
Gastro-esophageal reflux disease-Health related quality of life, GERD-HRQL
Time Frame: Before surgery and 3,6 and 12 months after surgery
|
The GERD-HRQL questionnaire evaluates heartburn, dysphagia and regurgitation on a scale from zero (no symptoms) to five (severe symptoms) in 15 questions.
Maximum score ranges from zero to 75 points
|
Before surgery and 3,6 and 12 months after surgery
|
|
Short From questionnaire (SF-36) Health related quality of life
Time Frame: before surgery and 3, 6 and 12 months after surgery
|
SF-36 is a well-established questionnaire consisting of 36 health related questions.
Scale is from 0-100 for each section (8 sections) A high score corresponds to a better health status
|
before surgery and 3, 6 and 12 months after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total number of patients with radiological recurrence after one year
Time Frame: one year after surgery
|
esophagus x-ray/barium swallow one year after surgery
|
one year after surgery
|
Collaborators and Investigators
Investigators
- Study Director: Kim Erlend Mortensen, MD, PhD, University of North Norway
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 625668 (REK)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Paraesophageal Hernia
-
Wake Forest University Health SciencesRecruitingHernia, ParaesophagealUnited States
-
Oulu University HospitalCentral Finland Hospital DistrictRecruitingRecurrence | Hiatal Hernia | Hiatal Hernia, Paraesophageal | Paraesophageal HerniaFinland
-
University of NebraskaLifeCellCompletedHiatal Hernia | Esophageal Hernia | Hernia, Esophageal | Hernia, Paraesophageal | Paraesophageal Hiatal Hernia | Sliding Esophageal Hernia | Sliding Hiatal HerniaUnited States
-
Spectrum Health HospitalsRecruitingParaesophageal HerniaUnited States
-
University of South FloridaIntegra LifeSciences CorporationCompleted
-
Ersta DiakoniKarolinska Institutet; Göteborg University; Sundsvall HospitalRecruitingParaesophageal HerniaSweden
-
Washington University School of MedicineMusculoskeletal Transplant FoundationCompleted
-
Karolinska InstitutetActive, not recruitingParaesophageal HerniaSweden
-
Cook Group IncorporatedCompletedHernia | Paraesophageal HerniaUnited States
-
University of WashingtonWashington University School of Medicine; Oregon Health and Science University and other collaboratorsUnknownHiatal Hernia | Paraesophageal HerniaUnited States
Clinical Trials on no intervention, but surgical practice as usual is continued. Its a pragmatic study
-
Nicoline LøkkenCompleted
-
Beijing Tiantan HospitalCompleted
-
BERTHILLIER JulienCompletedNeurological Disorder
-
The University of Texas Health Science Center,...CompletedWound InfectionUnited States
-
Hospices Civils de LyonRecruitingCystic Fibrosis (CF)France
-
Chinese University of Hong KongHospital Authority of Hong Kong (Bradbury Hospice)Completed
-
VA Office of Research and DevelopmentVA Boston Healthcare SystemRecruitingMild Cognitive Impairment | Mild Traumatic Brain Injury | Moderate Traumatic Brain InjuryUnited States